Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Julphar
Chubb
Healthtrust
Baxter
AstraZeneca
Dow
Daiichi Sankyo
McKinsey

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006333

« Back to Dashboard

NDA 006333 describes SYNOPHYLATE, which is a drug marketed by Cent Pharms and is included in one NDA. Additional details are available on the SYNOPHYLATE profile page.

The generic ingredient in SYNOPHYLATE is theophylline sodium glycinate. There are thirty-six drug master file entries for this compound. Additional details are available on the theophylline sodium glycinate profile page.
Summary for 006333
Tradename:SYNOPHYLATE
Applicant:Cent Pharms
Ingredient:theophylline sodium glycinate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 008

Active Rx/OTC/Discontinued:DISCNDosage:ELIXIR;ORALStrengthEQ 165MG BASE/15ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
McKinsey
Federal Trade Commission
Accenture
UBS
Julphar
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.